Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine

NCT00133146 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Type I Hypersensitivity

Interventions

BIOLOGICAL: Grass MATA MPL

Sponsor

Allergy Therapeutics